Lv M - Search Results

1

Exosomal miR-338-3p suppresses non-small-cell lung cancer cells metastasis by inhibiting CHL1 through the MAPK signaling pathway.

Tian W, Yang X, Yang H, Lv M, Sun X, Zhou B. Tian W, et al. Among authors: lv m. Cell Death Dis. 2021 Oct 30;12(11):1030. doi: 10.1038/s41419-021-04314-2. Cell Death Dis. 2021. PMID: 34718336 Free PMC article.

2

Correction: Exosomal miR-338-3p suppresses non-small-cell lung cancer cells metastasis by inhibiting CHL1 through the MAPK signaling pathway.

Tian W, Yang X, Yang H, Lv M, Sun X, Zhou B. Tian W, et al. Among authors: lv m. Cell Death Dis. 2022 May 19;13(5):473. doi: 10.1038/s41419-022-04933-3. Cell Death Dis. 2022. PMID: 35589682 Free PMC article. No abstract available.

3

ADGRD1 as a Potential Prognostic and Immunological Biomarker in Non-Small-Cell Lung Cancer.

Lv M, Li X, Tian W, Yang H, Zhou B. Lv M, et al. Biomed Res Int. 2022 Nov 22;2022:5699892. doi: 10.1155/2022/5699892. eCollection 2022. Biomed Res Int. 2022. PMID: 36457341 Free PMC article.

4

Comprehensive analysis and validation reveal DEPDC1 as a potential diagnostic biomarker associated with tumor immunity in non-small-cell lung cancer.

Lv M, Li X, Yin Z, Yang H, Zhou B. Lv M, et al. PLoS One. 2024 Apr 2;19(4):e0294227. doi: 10.1371/journal.pone.0294227. eCollection 2024. PLoS One. 2024. PMID: 38564630 Free PMC article.

5

Exosomal miR-130b-3p suppresses metastasis of non-small cell lung cancer cells by targeting DEPDC1 via TGF-β signaling pathway.

Lv M, Li X, Zheng C, Tian W, Yang H, Yin Z, Zhou B. Lv M, et al. Int J Biol Macromol. 2024 Aug;275(Pt 1):133594. doi: 10.1016/j.ijbiomac.2024.133594. Epub 2024 Jul 2. Int J Biol Macromol. 2024. PMID: 38960258 Free article.

6

Plant Adaptation and Soil Shear Strength: Unraveling the Drought Legacy in Amorpha fruticosa.

Jiang H, Chen X, Xu G, Chen J, Song D, Lv M, Guo H, Chen J. Jiang H, et al. Among authors: lv m. Plants (Basel). 2025 Jan 10;14(2):179. doi: 10.3390/plants14020179. Plants (Basel). 2025. PMID: 39861532

7

Long-term antibody trajectories after PPSV23 in elderly: Results from a 4-year follow-up study.

Zhou S, Wang J, Lv M, Lan W, Li J, Bai S, Zhao W, Suo L, Zhang A, Wu J. Zhou S, et al. Among authors: lv m. Vaccine. 2025 Jan 23;48:126737. doi: 10.1016/j.vaccine.2025.126737. Online ahead of print. Vaccine. 2025. PMID: 39855106

8

Nanocurcumin in myocardial infarction therapy: emerging trends and future directions.

Lv M, Sun Q, Yu Y, Bao J. Lv M, et al. Front Bioeng Biotechnol. 2025 Jan 8;12:1511331. doi: 10.3389/fbioe.2024.1511331. eCollection 2024. Front Bioeng Biotechnol. 2025. PMID: 39845374 Free PMC article. Review.

9

Deep learning-based synthetic CT for dosimetric monitoring of combined conventional radiotherapy and lattice boost in large lung tumors.

Zeng H, E X, Lv M, Zeng S, Feng Y, Shen W, Guan W, Zhang Y, Zhao R, Yu J. Zeng H, et al. Among authors: lv m. Radiat Oncol. 2025 Jan 22;20(1):12. doi: 10.1186/s13014-024-02568-6. Radiat Oncol. 2025. PMID: 39844209 Free PMC article.

10

Lidocaine could promote the cuproptosis through up-regulating the long noncoding RNA DNMBP-AS1 in Hep-2 cells.

Liu W, Yu Y, He Y, Lv M. Liu W, et al. Among authors: lv m. BMC Cancer. 2025 Jan 22;25(1):119. doi: 10.1186/s12885-025-13533-1. BMC Cancer. 2025. PMID: 39844114 Free PMC article.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

2,906 results

Search Page

Filters